Currax Pharmaceuticals
Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on addressing smoking and obesity, recognized as a 2022 Best Places to Work by Nashville Business Journal.
Company Overview
Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on addressing the leading causes of preventable deaths in the United States: smoking and obesity. The company is dedicated to developing and distributing a range of both branded and generic pharmaceutical products. It operates from its global headquarters located in Brentwood, Tennessee.
Product Line
Currax Pharmaceuticals LLC offers a variety of pharmaceutical products including Contrave®, Onzetra® Xsail®, Silenor®, and Treximet®, as well as an authorized generic version of Treximet®. CONTRAVE® is also marketed as MYSIMBA® in the European Union and the European Economic Area. CONTRAVE® is an extended-release fixed-dose combination of naltrexone and bupropion, targeting chronic weight management in adults.
Clinical Trials and Research
Currax Pharmaceuticals LLC is actively engaged in clinical research, evidenced by the commencement of the INFORMUS Cardiovascular Outcomes Trial (NB-CVOT3) on January 25, 2024. This Phase IV, multi-center, prospective, randomized, pragmatic, double-blinded, placebo-controlled study aims to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (CONTRAVE®). Additionally, a real-world evidence study announced on October 18, 2023, demonstrated no increased risk in major adverse cardiac events for patients taking CONTRAVE®.
Work Environment
Currax Pharmaceuticals LLC offers a robust benefits package including medical, dental, and vision insurance, company-paid short-term and long-term disability insurance, life and ADD insurance, 401(K) with company match, and an employee assistance program. The company was recognized as a Best Place to Work by the Nashville Business Journal in 2022, highlighting its commitment to fostering a supportive and respectful work environment.
Compliance and Ethics
Currax Pharmaceuticals LLC maintains a rigorous compliance program to ensure adherence to applicable laws, rules, and regulations related to the sale and marketing of its pharmaceutical products. The company employs a compliance officer and has established a compliance committee comprising senior management and other personnel to oversee compliance efforts and promote ethical decision-making.